Aaron Farberg, MD
MOHS-Micrographic Surgery · Rockwall, TXNPI 1134480239
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $947,731 of the $1,546,176 with a category attached, or 61.3%. It is spread thinly across 43 manufacturers, the largest accounting for just 15.4%. Among mohs-micrographic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,780 payments — averaging $868.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$239K
- Regeneron Healthcare Solutions, Inc.$186K
- Johnson & Johnson$167K
- Pfizer$164K
- Galderma Laboratories, L.p.$139K
- Boehringer Ingelheim$136K
- plus $516K from 37 others
Across 75 payments — averaging $4286.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$80K
- Takeda Pharmaceuticals U.S.A., Inc.$76K
- Incyte Corporation$63K
- Janssen Research & Development, LLC$51K
- Regeneron$41K
- Novartis$11K
- plus $1K from 1 others
What the payments were for
- Consulting fees$451,38729%
- Speaking & faculty fees$947,73161%
- Travel & lodging$102,1767%
- Food & beverage$39,9023%
- Education$4,9810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,546,176 in reported general payments places this provider in the 95th percentile of 109 mohs-micrographic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 80 | $1,015 |
| Mupirocin | 67 | $510 |
| Cephalexin | 47 | $370 |
| Clobetasol Propionate | 13 | $330 |
| Ketoconazole | 11 | $215 |
| Triamcinolone Acetonide | 13 | $145 |
| Tramadol Hcl | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Rockwall
- Suneel ChilukuriBellaire$288K
- Ryan O QuinnSan Antonio$167K
- Paul FriedmanHouston$131K
- Brent SpencerFrisco$45K
- Julie CroleyThe Woodlands$30K
- Kayla McNieceBellaire$13K
- Hubert ChodkiewiczCedar Park$13K
- Meredith OrsethCedar Hill$12K
- Saira MominGrapevine$11K
- Jessica DorseyCedar Park$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.